Unique ID issued by UMIN | UMIN000020010 |
---|---|
Receipt number | R000023101 |
Scientific Title | Validation study for anti-obesity effect and in healthy Japanese adults: a double-blind randomized controlled trial |
Date of disclosure of the study information | 2015/11/30 |
Last modified on | 2017/01/30 18:43:15 |
Validation study for anti-obesity effect and in healthy Japanese adults: a double-blind randomized controlled trial
Validation study for anti-obesity effect in healthy Japanese adults
Validation study for anti-obesity effect and in healthy Japanese adults: a double-blind randomized controlled trial
Validation study for anti-obesity effect in healthy Japanese adults
Japan |
Healthy adults
Not applicable | Adult |
Others
NO
We investigate the effect of tet foods ("Oligonol" or "pumpkin extract") on anti-obesity effect in healthy Japanese adults.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
total fat area(0 weeks & 8 weeks)
subcutaneous fat area(0 weeks & 8 weeks)
visceral fat area(0 weeks & 8 weeks)
body weight
body mass index
body fat percentage
waist circumference
adiponectin
total cholesterol
high-density lipoprotein cholesterol
low-density lipoprotein cholesterol
triglyceride
free fatty acid
subjective symptom (Likert scale)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
3
Treatment
Food |
Period: 12 weeks
Test food: Oligonol
Dose: once a day (2 capsules for once)
Usage: ingestion of the test food along with the water or hot water after the meal
Period: 12 weeks
Test food: Pumpkin extract
Dose: once a day (2 capsules for once)
Usage: ingestion of the test food along with the water or hot water after the meal
Period: 12 weeks
Test food: placebo
Dose: once a day (2 capsules for once)
Usage: ingestion of the test food along with the water or hot water after the meal
20 | years-old | <= |
Not applicable |
Male and Female
1. Healthy Japanese adults
2. BMI (25 kg/m2 to less than 30 kg/m2)
1. At least one previous medical history of malignant tumor, heart failure or myocardial infarction
2. Currently under the treatment for either atrial fibrillation, cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension or other chronic diseases
3. Currently taking medicines, herbal medicines
4. Allergic to medicines or foods related to the test food (including polyphenol, lychee, pumpkin) of this trial
5. Pregnant, lactating, or planning to get pregnant during the trial period
6. Enrolled into other clinical trials within the last 3 months before agreeing to participate in this trial
7. Judged unsuitable for participating in this trial by physician
30
1st name | |
Middle name | |
Last name | Kazuo YAMAMOTO |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
kazu@orthomedico.jp
1st name | |
Middle name | |
Last name | Naoko SUZUKI |
ORTHOMEDICO, Inc.
R&D Department
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1 Koishikawa, Bunkyo-ku, Tokyo.
03-3818-0610
nao@orthomedico.jp
ORTHOMEDICO, Inc.
AMINO UP CHEMICAL Co.,Ltd.
Profit organization
Seishin-kai Medical Association Inc, Takara Medical Clinic.
NO
医療法人社団 盛心会 タカラクリニック (東京都)
Seishin-kai Medical Association Inc, Takara Medical Clinic (Tokyo)
2015 | Year | 11 | Month | 30 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 30 | Day |
2015 | Year | 12 | Month | 01 | Day |
2016 | Year | 03 | Month | 12 | Day |
2016 | Year | 03 | Month | 20 | Day |
2016 | Year | 03 | Month | 20 | Day |
2016 | Year | 03 | Month | 20 | Day |
2015 | Year | 11 | Month | 30 | Day |
2017 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023101